Table 3.
Univariate logistic regression analysis of variables potentially associated with venous thromboembolism.
| Parameter | Odds Ratio | p Value | Confidence Interval |
|---|---|---|---|
| Age (Continuous) | 1.01 | 0.60 | 0.96–1.07 |
| BMI (Continuous) | 1.01 | 0.73 | 0.96–1.06 |
| Race (Nonwhite vs White) | 1.34 | 0.71 | 0.29–6.22 |
| Current Smoker (Yes vs No) | 1.84 | 0.58 | 0.22–15.56 |
| Non-endometrioid Histology (vs Endometrioid) | 1.15 | 0.78 | 0.43–3.06 |
| FIGO Grade (High vs Low) | 0.89 | 0.81 | 0.33–2.36 |
| FIGO Stage (III-IV vs I-II) | 2.01 | 0.23 | 0.64–6.27 |
| Radiation (Yes vs No) | 0.44 | 0.10 | 0.17–1.18 |
| NA/DCT (vs ACT) | 2.45 | 0.11 | 0.82–7.30 |
| Surgery with Laparotomy (Yes vs No) | 2.48 | 0.07 | 0.94–6.55 |
| Residual or Measurable Disease (Yes vs No) | 4.78 | 0.002* | 1.77–12.90 |
| Platelet ≥ 350 × 109/L (Yes vs No) | 1.29 | 0.62 | 0.47–3.57 |
| Hemoglobin ≤ 10 g/L (Yes vs No) | 3.25 | 0.02* | 1.22–8.64 |
| WBC > 11 × 109/L (Yes vs No) | 1.47 | 0.56 | 0.40–5.35 |
FIGO = International Federation of Gynecology and Obstetrics, NA/DCT = neoadjuvant/definitive chemotherapy, ACT = adjuvant chemotherapy.
*Denotes statistically significant (p < 0.05).